Clinical Trial Update: Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a combination of oblimersen with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with stage II-IV dif…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Deltasone (prednisone)
• Genasense (oblimersen)
• Oncovin (vincristine)
• Rituxan (rituximab)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Lymphoma | Phase 1 | Status: COMPLETED